Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry to track management and outcomes of patients with complex coronary artery disease

Official title: COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

Run by Luzerner Kantonsspital · NCT06075602 · Data updated 2026-11-12

This study is tracking how well different treatments for complex coronary artery disease work in patients who have had procedures like stents or bypass surgery.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorLuzerner Kantonsspital
Academic / other
Locations1 site (Lucerne, Canton of Lucerne)
StatusRecruiting
StartedNovember 1, 2021
Main results expectedDecember 31, 2031
Study endsDecember 31, 2031
Registry record updatedOctober 29, 2024
Trial IDNCT06075602 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with chronic, complex, and/or calcified coronary artery disease requiring PCI or CABG.

Probably not a fit

Patients under 18 or those without complex and calcified coronary artery disease will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The COMPLEX Registry aims to collect both baseline and clinical data from patients who have undergone percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) for complex and calcified coronary artery disease. This observational study will analyze procedural outcomes and complications, comparing results across different clinical subgroups. It will also assess the impact of various PCI techniques and CABG strategies on cardiovascular outcomes, including short and long-term clinical results. Data will be collected prospectively and retrospectively to provide a comprehensive overview of patient management and outcomes.

Why it matters

Potential benefit: If successful, this registry could improve treatment strategies and outcomes for patients with complex coronary artery disease.

How similar studies have gone: Other studies have shown success in tracking outcomes for coronary interventions, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject \>18 years of age
* Individuals presenting with chronic, complex and/or calcified CAD and requiring PCI or CABG
* Complex coronary artery disease / lesions must include at least one of the following attributes:
* Long and/ or heavily calcified coronary lesions
* In-stent restenosis
* Chronic total occlusions (CTO)
* Left main lesions
* Bifurcation lesions
* Bypass graft lesions
* Small vessel disease / coronary microvascular dysfunction (e.g. not amenable to PCI)
* Subjects must be willing to sign a patient informed consent (PIC) or must have signed the General Consent (GK).

Exclusion Criteria:

The presence of any one of the following exclusion criteria will lead to exclusion of the patient.

* Patient is \<18 years of age
* Patient unwilling or unable to provide informed consent
* Patients with no complex and calcified CAD

Where it's running

  • Lucerne Heart Centre
    Lucerne, Canton of Lucerne, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.